nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotetan—ALB—type 2 diabetes mellitus	0.309	1	CbGaD
Cefotetan—ALB—Gliclazide—type 2 diabetes mellitus	0.103	0.204	CbGbCtD
Cefotetan—ALB—Repaglinide—type 2 diabetes mellitus	0.0971	0.192	CbGbCtD
Cefotetan—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0811	0.16	CbGbCtD
Cefotetan—ALB—Valsartan—type 2 diabetes mellitus	0.0716	0.142	CbGbCtD
Cefotetan—ALB—Nateglinide—type 2 diabetes mellitus	0.0666	0.132	CbGbCtD
Cefotetan—ALB—Glyburide—type 2 diabetes mellitus	0.045	0.0889	CbGbCtD
Cefotetan—ALB—Losartan—type 2 diabetes mellitus	0.0411	0.0813	CbGbCtD
Cefotetan—Cefazolin—PON1—type 2 diabetes mellitus	0.00115	0.488	CrCbGaD
Cefotetan—Urticaria—Tolazamide—type 2 diabetes mellitus	0.000508	0.00373	CcSEcCtD
Cefotetan—Urticaria—Linagliptin—type 2 diabetes mellitus	0.000503	0.00369	CcSEcCtD
Cefotetan—Gastrointestinal pain—Acarbose—type 2 diabetes mellitus	0.000503	0.00369	CcSEcCtD
Cefotetan—Thrombocytopenia—Repaglinide—type 2 diabetes mellitus	0.000502	0.00369	CcSEcCtD
Cefotetan—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.000498	0.00365	CcSEcCtD
Cefotetan—Rash—Miglitol—type 2 diabetes mellitus	0.000493	0.00362	CcSEcCtD
Cefotetan—Dermatitis—Miglitol—type 2 diabetes mellitus	0.000493	0.00361	CcSEcCtD
Cefotetan—Haemolytic anaemia—Losartan—type 2 diabetes mellitus	0.000491	0.0036	CcSEcCtD
Cefotetan—Pancytopenia—Gliclazide—type 2 diabetes mellitus	0.00049	0.00359	CcSEcCtD
Cefotetan—Urticaria—Acarbose—type 2 diabetes mellitus	0.000488	0.00358	CcSEcCtD
Cefotetan—Abdominal pain—Acarbose—type 2 diabetes mellitus	0.000486	0.00357	CcSEcCtD
Cefotetan—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.000485	0.00356	CcSEcCtD
Cefotetan—Gastrointestinal pain—Nateglinide—type 2 diabetes mellitus	0.000485	0.00356	CcSEcCtD
Cefotetan—Agranulocytosis—Glyburide—type 2 diabetes mellitus	0.000478	0.00351	CcSEcCtD
Cefotetan—Thrombocytopenia—Rosiglitazone—type 2 diabetes mellitus	0.000475	0.00348	CcSEcCtD
Cefotetan—Urticaria—Nateglinide—type 2 diabetes mellitus	0.000471	0.00345	CcSEcCtD
Cefotetan—Abdominal pain—Nateglinide—type 2 diabetes mellitus	0.000469	0.00344	CcSEcCtD
Cefotetan—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.000467	0.00342	CcSEcCtD
Cefotetan—Leukopenia—Glipizide—type 2 diabetes mellitus	0.000466	0.00342	CcSEcCtD
Cefotetan—Nausea—Miglitol—type 2 diabetes mellitus	0.000465	0.00341	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Gliclazide—type 2 diabetes mellitus	0.000456	0.00335	CcSEcCtD
Cefotetan—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.000453	0.00332	CcSEcCtD
Cefotetan—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.000453	0.00332	CcSEcCtD
Cefotetan—Pruritus—Tolazamide—type 2 diabetes mellitus	0.000453	0.00332	CcSEcCtD
Cefotetan—Rash—Tolbutamide—type 2 diabetes mellitus	0.000443	0.00325	CcSEcCtD
Cefotetan—Neutropenia—Valsartan—type 2 diabetes mellitus	0.000443	0.00325	CcSEcCtD
Cefotetan—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.000438	0.00321	CcSEcCtD
Cefotetan—Discomfort—Glipizide—type 2 diabetes mellitus	0.000438	0.00321	CcSEcCtD
Cefotetan—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.000437	0.0032	CcSEcCtD
Cefotetan—Leukopenia—Glimepiride—type 2 diabetes mellitus	0.000434	0.00319	CcSEcCtD
Cefotetan—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.000433	0.00318	CcSEcCtD
Cefotetan—Agranulocytosis—Gliclazide—type 2 diabetes mellitus	0.000429	0.00315	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Irbesartan—type 2 diabetes mellitus	0.000424	0.00311	CcSEcCtD
Cefotetan—Haemolytic anaemia—Ramipril—type 2 diabetes mellitus	0.000421	0.00309	CcSEcCtD
Cefotetan—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.000421	0.00309	CcSEcCtD
Cefotetan—Convulsion—Glimepiride—type 2 diabetes mellitus	0.000421	0.00309	CcSEcCtD
Cefotetan—Gastrointestinal pain—Repaglinide—type 2 diabetes mellitus	0.00042	0.00308	CcSEcCtD
Cefotetan—Pruritus—Nateglinide—type 2 diabetes mellitus	0.000419	0.00308	CcSEcCtD
Cefotetan—Discomfort—Pioglitazone—type 2 diabetes mellitus	0.000419	0.00307	CcSEcCtD
Cefotetan—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000418	0.00306	CcSEcCtD
Cefotetan—Thrombocytopenia—Glipizide—type 2 diabetes mellitus	0.000416	0.00305	CcSEcCtD
Cefotetan—Urticaria—Repaglinide—type 2 diabetes mellitus	0.000408	0.00299	CcSEcCtD
Cefotetan—Discomfort—Sitagliptin—type 2 diabetes mellitus	0.000407	0.00299	CcSEcCtD
Cefotetan—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000407	0.00298	CcSEcCtD
Cefotetan—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.000407	0.00298	CcSEcCtD
Cefotetan—Abdominal pain—Repaglinide—type 2 diabetes mellitus	0.000406	0.00298	CcSEcCtD
Cefotetan—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.000406	0.00298	CcSEcCtD
Cefotetan—Neutropenia—Metformin—type 2 diabetes mellitus	0.000404	0.00296	CcSEcCtD
Cefotetan—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000403	0.00296	CcSEcCtD
Cefotetan—Rash—Tolazamide—type 2 diabetes mellitus	0.000403	0.00296	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Losartan—type 2 diabetes mellitus	0.000399	0.00293	CcSEcCtD
Cefotetan—Rash—Linagliptin—type 2 diabetes mellitus	0.000399	0.00293	CcSEcCtD
Cefotetan—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000399	0.00293	CcSEcCtD
Cefotetan—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.000396	0.00291	CcSEcCtD
Cefotetan—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.000395	0.0029	CcSEcCtD
Cefotetan—Vomiting—Acarbose—type 2 diabetes mellitus	0.000391	0.00287	CcSEcCtD
Cefotetan—Erythema multiforme—Gliclazide—type 2 diabetes mellitus	0.00039	0.00286	CcSEcCtD
Cefotetan—Thrombocytopenia—Glimepiride—type 2 diabetes mellitus	0.000388	0.00285	CcSEcCtD
Cefotetan—Rash—Acarbose—type 2 diabetes mellitus	0.000388	0.00284	CcSEcCtD
Cefotetan—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000387	0.00284	CcSEcCtD
Cefotetan—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.000385	0.00283	CcSEcCtD
Cefotetan—Haemoglobin—Valsartan—type 2 diabetes mellitus	0.000381	0.0028	CcSEcCtD
Cefotetan—Neutropenia—Irbesartan—type 2 diabetes mellitus	0.000381	0.00279	CcSEcCtD
Cefotetan—Nausea—Tolazamide—type 2 diabetes mellitus	0.00038	0.00279	CcSEcCtD
Cefotetan—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00038	0.00279	CcSEcCtD
Cefotetan—Eosinophilia—Losartan—type 2 diabetes mellitus	0.00038	0.00278	CcSEcCtD
Cefotetan—Convulsion—Bromocriptine—type 2 diabetes mellitus	0.000379	0.00278	CcSEcCtD
Cefotetan—Haemorrhage—Valsartan—type 2 diabetes mellitus	0.000379	0.00278	CcSEcCtD
Cefotetan—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000378	0.00277	CcSEcCtD
Cefotetan—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000377	0.00276	CcSEcCtD
Cefotetan—Haemoglobin—Orlistat—type 2 diabetes mellitus	0.000377	0.00276	CcSEcCtD
Cefotetan—Haemorrhage—Orlistat—type 2 diabetes mellitus	0.000375	0.00275	CcSEcCtD
Cefotetan—Rash—Nateglinide—type 2 diabetes mellitus	0.000374	0.00274	CcSEcCtD
Cefotetan—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000373	0.00274	CcSEcCtD
Cefotetan—Nausea—Acarbose—type 2 diabetes mellitus	0.000365	0.00268	CcSEcCtD
Cefotetan—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000363	0.00266	CcSEcCtD
Cefotetan—Leukopenia—Glyburide—type 2 diabetes mellitus	0.000358	0.00263	CcSEcCtD
Cefotetan—Nausea—Nateglinide—type 2 diabetes mellitus	0.000352	0.00258	CcSEcCtD
Cefotetan—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000351	0.00258	CcSEcCtD
Cefotetan—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.000347	0.00255	CcSEcCtD
Cefotetan—Convulsion—Glyburide—type 2 diabetes mellitus	0.000347	0.00254	CcSEcCtD
Cefotetan—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000343	0.00252	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Ramipril—type 2 diabetes mellitus	0.000342	0.00251	CcSEcCtD
Cefotetan—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000339	0.00249	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Losartan—type 2 diabetes mellitus	0.000339	0.00249	CcSEcCtD
Cefotetan—Urticaria—Glipizide—type 2 diabetes mellitus	0.000337	0.00247	CcSEcCtD
Cefotetan—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000336	0.00246	CcSEcCtD
Cefotetan—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000332	0.00243	CcSEcCtD
Cefotetan—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000326	0.00239	CcSEcCtD
Cefotetan—Eosinophilia—Ramipril—type 2 diabetes mellitus	0.000325	0.00239	CcSEcCtD
Cefotetan—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000324	0.00238	CcSEcCtD
Cefotetan—Rash—Repaglinide—type 2 diabetes mellitus	0.000323	0.00237	CcSEcCtD
Cefotetan—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000323	0.00237	CcSEcCtD
Cefotetan—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000323	0.00237	CcSEcCtD
Cefotetan—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000323	0.00237	CcSEcCtD
Cefotetan—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000322	0.00236	CcSEcCtD
Cefotetan—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.00032	0.00235	CcSEcCtD
Cefotetan—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000319	0.00234	CcSEcCtD
Cefotetan—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000315	0.00231	CcSEcCtD
Cefotetan—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000314	0.0023	CcSEcCtD
Cefotetan—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000313	0.0023	CcSEcCtD
Cefotetan—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000313	0.00229	CcSEcCtD
Cefotetan—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000312	0.00229	CcSEcCtD
Cefotetan—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.000312	0.00229	CcSEcCtD
Cefotetan—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000311	0.00228	CcSEcCtD
Cefotetan—Neutropenia—Ramipril—type 2 diabetes mellitus	0.000307	0.00225	CcSEcCtD
Cefotetan—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000306	0.00224	CcSEcCtD
Cefotetan—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000305	0.00224	CcSEcCtD
Cefotetan—Nausea—Repaglinide—type 2 diabetes mellitus	0.000305	0.00224	CcSEcCtD
Cefotetan—Cefpiramide—ALB—type 2 diabetes mellitus	0.000304	0.129	CrCbGaD
Cefotetan—Discomfort—Gliclazide—type 2 diabetes mellitus	0.000302	0.00222	CcSEcCtD
Cefotetan—Pruritus—Glipizide—type 2 diabetes mellitus	0.0003	0.0022	CcSEcCtD
Cefotetan—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.0003	0.0022	CcSEcCtD
Cefotetan—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000292	0.00214	CcSEcCtD
Cefotetan—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000292	0.00214	CcSEcCtD
Cefotetan—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000291	0.00213	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000291	0.00213	CcSEcCtD
Cefotetan—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00029	0.00213	CcSEcCtD
Cefotetan—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.00029	0.00213	CcSEcCtD
Cefotetan—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000288	0.00211	CcSEcCtD
Cefotetan—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000287	0.00211	CcSEcCtD
Cefotetan—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000284	0.00208	CcSEcCtD
Cefotetan—Convulsion—Orlistat—type 2 diabetes mellitus	0.000283	0.00207	CcSEcCtD
Cefotetan—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000283	0.00207	CcSEcCtD
Cefotetan—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000283	0.00207	CcSEcCtD
Cefotetan—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00028	0.00206	CcSEcCtD
Cefotetan—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000278	0.00204	CcSEcCtD
Cefotetan—Discomfort—Orlistat—type 2 diabetes mellitus	0.000274	0.00201	CcSEcCtD
Cefotetan—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000273	0.00201	CcSEcCtD
Cefotetan—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000271	0.00199	CcSEcCtD
Cefotetan—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00027	0.00198	CcSEcCtD
Cefotetan—Vomiting—Glipizide—type 2 diabetes mellitus	0.00027	0.00198	CcSEcCtD
Cefotetan—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00027	0.00198	CcSEcCtD
Cefotetan—Rash—Glipizide—type 2 diabetes mellitus	0.000268	0.00196	CcSEcCtD
Cefotetan—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000267	0.00196	CcSEcCtD
Cefotetan—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000267	0.00196	CcSEcCtD
Cefotetan—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000266	0.00195	CcSEcCtD
Cefotetan—Cefonicid—ALB—type 2 diabetes mellitus	0.000265	0.112	CrCbGaD
Cefotetan—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000264	0.00194	CcSEcCtD
Cefotetan—Urticaria—Glyburide—type 2 diabetes mellitus	0.00026	0.0019	CcSEcCtD
Cefotetan—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000258	0.00189	CcSEcCtD
Cefotetan—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000254	0.00186	CcSEcCtD
Cefotetan—Discomfort—Metformin—type 2 diabetes mellitus	0.000253	0.00186	CcSEcCtD
Cefotetan—Nausea—Glipizide—type 2 diabetes mellitus	0.000252	0.00185	CcSEcCtD
Cefotetan—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000252	0.00185	CcSEcCtD
Cefotetan—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000251	0.00184	CcSEcCtD
Cefotetan—Rash—Glimepiride—type 2 diabetes mellitus	0.00025	0.00183	CcSEcCtD
Cefotetan—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00025	0.00183	CcSEcCtD
Cefotetan—Rash—Sitagliptin—type 2 diabetes mellitus	0.000249	0.00183	CcSEcCtD
Cefotetan—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000249	0.00182	CcSEcCtD
Cefotetan—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000249	0.00182	CcSEcCtD
Cefotetan—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000245	0.00179	CcSEcCtD
Cefotetan—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000241	0.00177	CcSEcCtD
Cefotetan—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.00024	0.00176	CcSEcCtD
Cefotetan—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.00024	0.00176	CcSEcCtD
Cefotetan—Leukopenia—Losartan—type 2 diabetes mellitus	0.000239	0.00175	CcSEcCtD
Cefotetan—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000239	0.00175	CcSEcCtD
Cefotetan—Nausea—Glimepiride—type 2 diabetes mellitus	0.000235	0.00173	CcSEcCtD
Cefotetan—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000235	0.00172	CcSEcCtD
Cefotetan—Cefmetazole—ALB—type 2 diabetes mellitus	0.000233	0.0988	CrCbGaD
Cefotetan—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000233	0.00171	CcSEcCtD
Cefotetan—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000232	0.0017	CcSEcCtD
Cefotetan—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000232	0.0017	CcSEcCtD
Cefotetan—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000232	0.0017	CcSEcCtD
Cefotetan—Pruritus—Glyburide—type 2 diabetes mellitus	0.000231	0.0017	CcSEcCtD
Cefotetan—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000227	0.00167	CcSEcCtD
Cefotetan—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000227	0.00166	CcSEcCtD
Cefotetan—Rash—Bromocriptine—type 2 diabetes mellitus	0.000225	0.00165	CcSEcCtD
Cefotetan—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000225	0.00165	CcSEcCtD
Cefotetan—Discomfort—Losartan—type 2 diabetes mellitus	0.000225	0.00165	CcSEcCtD
Cefotetan—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000224	0.00164	CcSEcCtD
Cefotetan—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.00022	0.00162	CcSEcCtD
Cefotetan—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000218	0.0016	CcSEcCtD
Cefotetan—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000218	0.0016	CcSEcCtD
Cefotetan—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000216	0.00159	CcSEcCtD
Cefotetan—Urticaria—Valsartan—type 2 diabetes mellitus	0.000214	0.00157	CcSEcCtD
Cefotetan—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000213	0.00157	CcSEcCtD
Cefotetan—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000213	0.00156	CcSEcCtD
Cefotetan—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000212	0.00156	CcSEcCtD
Cefotetan—Urticaria—Orlistat—type 2 diabetes mellitus	0.000212	0.00155	CcSEcCtD
Cefotetan—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000211	0.00154	CcSEcCtD
Cefotetan—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000211	0.00154	CcSEcCtD
Cefotetan—Vomiting—Glyburide—type 2 diabetes mellitus	0.000208	0.00152	CcSEcCtD
Cefotetan—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000208	0.00152	CcSEcCtD
Cefotetan—Rash—Glyburide—type 2 diabetes mellitus	0.000206	0.00151	CcSEcCtD
Cefotetan—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000206	0.00151	CcSEcCtD
Cefotetan—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000205	0.0015	CcSEcCtD
Cefotetan—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000201	0.00147	CcSEcCtD
Cefotetan—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000201	0.00147	CcSEcCtD
Cefotetan—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000199	0.00146	CcSEcCtD
Cefotetan—Convulsion—Ramipril—type 2 diabetes mellitus	0.000198	0.00146	CcSEcCtD
Cefotetan—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000196	0.00144	CcSEcCtD
Cefotetan—Urticaria—Metformin—type 2 diabetes mellitus	0.000195	0.00143	CcSEcCtD
Cefotetan—Nausea—Glyburide—type 2 diabetes mellitus	0.000194	0.00142	CcSEcCtD
Cefotetan—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000194	0.00142	CcSEcCtD
Cefotetan—Discomfort—Ramipril—type 2 diabetes mellitus	0.000193	0.00141	CcSEcCtD
Cefotetan—Pruritus—Valsartan—type 2 diabetes mellitus	0.000191	0.0014	CcSEcCtD
Cefotetan—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000189	0.00139	CcSEcCtD
Cefotetan—Pruritus—Orlistat—type 2 diabetes mellitus	0.000188	0.00138	CcSEcCtD
Cefotetan—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000187	0.00137	CcSEcCtD
Cefotetan—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000187	0.00137	CcSEcCtD
Cefotetan—Rash—Gliclazide—type 2 diabetes mellitus	0.000185	0.00136	CcSEcCtD
Cefotetan—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000185	0.00136	CcSEcCtD
Cefotetan—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000184	0.00135	CcSEcCtD
Cefotetan—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000184	0.00135	CcSEcCtD
Cefotetan—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000183	0.00134	CcSEcCtD
Cefotetan—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000183	0.00134	CcSEcCtD
Cefotetan—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000183	0.00134	CcSEcCtD
Cefotetan—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000182	0.00134	CcSEcCtD
Cefotetan—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000178	0.00131	CcSEcCtD
Cefotetan—Nausea—Gliclazide—type 2 diabetes mellitus	0.000174	0.00128	CcSEcCtD
Cefotetan—Pruritus—Metformin—type 2 diabetes mellitus	0.000174	0.00127	CcSEcCtD
Cefotetan—Urticaria—Losartan—type 2 diabetes mellitus	0.000173	0.00127	CcSEcCtD
Cefotetan—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000172	0.00126	CcSEcCtD
Cefotetan—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000172	0.00126	CcSEcCtD
Cefotetan—Vomiting—Valsartan—type 2 diabetes mellitus	0.000171	0.00126	CcSEcCtD
Cefotetan—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000171	0.00125	CcSEcCtD
Cefotetan—Rash—Valsartan—type 2 diabetes mellitus	0.00017	0.00125	CcSEcCtD
Cefotetan—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00017	0.00125	CcSEcCtD
Cefotetan—Vomiting—Orlistat—type 2 diabetes mellitus	0.000169	0.00124	CcSEcCtD
Cefotetan—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000168	0.00123	CcSEcCtD
Cefotetan—Rash—Orlistat—type 2 diabetes mellitus	0.000168	0.00123	CcSEcCtD
Cefotetan—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000168	0.00123	CcSEcCtD
Cefotetan—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000164	0.0012	CcSEcCtD
Cefotetan—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000161	0.00118	CcSEcCtD
Cefotetan—Nausea—Valsartan—type 2 diabetes mellitus	0.00016	0.00117	CcSEcCtD
Cefotetan—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000158	0.00116	CcSEcCtD
Cefotetan—Nausea—Orlistat—type 2 diabetes mellitus	0.000158	0.00116	CcSEcCtD
Cefotetan—Cefoperazone—ALB—type 2 diabetes mellitus	0.000156	0.0661	CrCbGaD
Cefotetan—Vomiting—Metformin—type 2 diabetes mellitus	0.000156	0.00114	CcSEcCtD
Cefotetan—Rash—Metformin—type 2 diabetes mellitus	0.000155	0.00114	CcSEcCtD
Cefotetan—Dermatitis—Metformin—type 2 diabetes mellitus	0.000155	0.00113	CcSEcCtD
Cefotetan—Pruritus—Losartan—type 2 diabetes mellitus	0.000154	0.00113	CcSEcCtD
Cefotetan—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000153	0.00112	CcSEcCtD
Cefotetan—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000149	0.00109	CcSEcCtD
Cefotetan—Urticaria—Ramipril—type 2 diabetes mellitus	0.000148	0.00109	CcSEcCtD
Cefotetan—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000148	0.00108	CcSEcCtD
Cefotetan—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000148	0.00108	CcSEcCtD
Cefotetan—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000147	0.00108	CcSEcCtD
Cefotetan—Rash—Irbesartan—type 2 diabetes mellitus	0.000146	0.00107	CcSEcCtD
Cefotetan—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000146	0.00107	CcSEcCtD
Cefotetan—Nausea—Metformin—type 2 diabetes mellitus	0.000146	0.00107	CcSEcCtD
Cefotetan—Vomiting—Losartan—type 2 diabetes mellitus	0.000139	0.00102	CcSEcCtD
Cefotetan—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000138	0.00101	CcSEcCtD
Cefotetan—Nausea—Irbesartan—type 2 diabetes mellitus	0.000138	0.00101	CcSEcCtD
Cefotetan—Rash—Losartan—type 2 diabetes mellitus	0.000137	0.00101	CcSEcCtD
Cefotetan—Dermatitis—Losartan—type 2 diabetes mellitus	0.000137	0.00101	CcSEcCtD
Cefotetan—Pruritus—Ramipril—type 2 diabetes mellitus	0.000132	0.00097	CcSEcCtD
Cefotetan—Nausea—Losartan—type 2 diabetes mellitus	0.000129	0.00095	CcSEcCtD
Cefotetan—ALB—Selenium Micronutrient Network—CAT—type 2 diabetes mellitus	0.000128	0.00275	CbGpPWpGaD
Cefotetan—Cefazolin—ALB—type 2 diabetes mellitus	0.000128	0.0543	CrCbGaD
Cefotetan—ALB—Folate Metabolism—CRP—type 2 diabetes mellitus	0.000128	0.00275	CbGpPWpGaD
Cefotetan—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000128	0.000938	CcSEcCtD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000126	0.0027	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000126	0.00269	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—APOB—type 2 diabetes mellitus	0.000125	0.00267	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—APOA1—type 2 diabetes mellitus	0.000124	0.00266	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—CD36—type 2 diabetes mellitus	0.000122	0.00261	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—SOD2—type 2 diabetes mellitus	0.000122	0.0026	CbGpPWpGaD
Cefotetan—Ceftriaxone—ALB—type 2 diabetes mellitus	0.000122	0.0515	CrCbGaD
Cefotetan—ALB—Vitamin B12 Metabolism—SERPINE1—type 2 diabetes mellitus	0.000121	0.00259	CbGpPWpGaD
Cefotetan—Vomiting—Ramipril—type 2 diabetes mellitus	0.000119	0.000872	CcSEcCtD
Cefotetan—ALB—Folate Metabolism—ICAM1—type 2 diabetes mellitus	0.000118	0.00252	CbGpPWpGaD
Cefotetan—Rash—Ramipril—type 2 diabetes mellitus	0.000118	0.000865	CcSEcCtD
Cefotetan—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000118	0.000864	CcSEcCtD
Cefotetan—ALB—Hemostasis—GRB14—type 2 diabetes mellitus	0.000117	0.0025	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—CD36—type 2 diabetes mellitus	0.000116	0.00249	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—GPX1—type 2 diabetes mellitus	0.000116	0.00248	CbGpPWpGaD
Cefotetan—Nausea—Ramipril—type 2 diabetes mellitus	0.000111	0.000814	CcSEcCtD
Cefotetan—ALB—Vitamin B12 Metabolism—RELA—type 2 diabetes mellitus	0.000109	0.00233	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—CALM1—type 2 diabetes mellitus	0.000108	0.00231	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—INS—type 2 diabetes mellitus	0.000107	0.0023	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—MTHFR—type 2 diabetes mellitus	0.000107	0.00229	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000107	0.00229	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—APOA1—type 2 diabetes mellitus	0.000106	0.00228	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	0.000106	0.00227	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—CCL2—type 2 diabetes mellitus	0.000106	0.00226	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000103	0.00221	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—CALM1—type 2 diabetes mellitus	0.000103	0.0022	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—CRP—type 2 diabetes mellitus	0.000102	0.00218	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—APOA1—type 2 diabetes mellitus	0.000101	0.00217	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	0.000101	0.00215	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—APOA1—type 2 diabetes mellitus	9.87e-05	0.00211	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—SERPINE1—type 2 diabetes mellitus	9.86e-05	0.00211	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—PRKCB—type 2 diabetes mellitus	9.68e-05	0.00207	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—ICAM1—type 2 diabetes mellitus	9.37e-05	0.002	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—NFKB1—type 2 diabetes mellitus	9.18e-05	0.00196	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—TRPC6—type 2 diabetes mellitus	9.06e-05	0.00194	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—IGF1—type 2 diabetes mellitus	8.9e-05	0.0019	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—RELA—type 2 diabetes mellitus	8.86e-05	0.00189	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	8.59e-05	0.00184	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—INS—type 2 diabetes mellitus	8.53e-05	0.00182	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—type 2 diabetes mellitus	8.48e-05	0.00181	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—SERPINE1—type 2 diabetes mellitus	8.45e-05	0.00181	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	8.43e-05	0.0018	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—CCL2—type 2 diabetes mellitus	8.39e-05	0.00179	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	8.2e-05	0.00175	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	8.14e-05	0.00174	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	8.14e-05	0.00174	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—type 2 diabetes mellitus	8.05e-05	0.00172	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	8.01e-05	0.00171	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—ADRA2A—type 2 diabetes mellitus	7.98e-05	0.00171	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—TIMP1—type 2 diabetes mellitus	7.94e-05	0.0017	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—SERPINE1—type 2 diabetes mellitus	7.83e-05	0.00167	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	7.83e-05	0.00167	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	7.63e-05	0.00163	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—NFKB1—type 2 diabetes mellitus	7.47e-05	0.0016	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	7.45e-05	0.00159	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	7.28e-05	0.00156	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	7.28e-05	0.00156	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	7.28e-05	0.00156	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PTPN1—type 2 diabetes mellitus	7.26e-05	0.00155	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—RASGRP1—type 2 diabetes mellitus	7.15e-05	0.00153	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—TNF—type 2 diabetes mellitus	7.14e-05	0.00153	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—RELA—type 2 diabetes mellitus	7.04e-05	0.00151	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—PTGS2—type 2 diabetes mellitus	6.84e-05	0.00146	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—ATP2A3—type 2 diabetes mellitus	6.7e-05	0.00143	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	6.65e-05	0.00142	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	6.64e-05	0.00142	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	6.64e-05	0.00142	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	6.6e-05	0.00141	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	6.49e-05	0.00139	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—SOD1—type 2 diabetes mellitus	6.47e-05	0.00138	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	6.39e-05	0.00137	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	6.39e-05	0.00137	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	6.38e-05	0.00136	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	6.28e-05	0.00134	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—GNB3—type 2 diabetes mellitus	6.26e-05	0.00134	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—IGF2—type 2 diabetes mellitus	6.15e-05	0.00131	CbGpPWpGaD
Cefotetan—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—type 2 diabetes mellitus	5.98e-05	0.00128	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—NFKB1—type 2 diabetes mellitus	5.94e-05	0.00127	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—VEGFA—type 2 diabetes mellitus	5.81e-05	0.00124	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—TNF—type 2 diabetes mellitus	5.81e-05	0.00124	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	5.8e-05	0.00124	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—IL6—type 2 diabetes mellitus	5.76e-05	0.00123	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—THBD—type 2 diabetes mellitus	5.7e-05	0.00122	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—type 2 diabetes mellitus	5.54e-05	0.00118	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	5.52e-05	0.00118	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	5.52e-05	0.00118	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	5.43e-05	0.00116	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	5.42e-05	0.00116	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—CD36—type 2 diabetes mellitus	5.42e-05	0.00116	CbGpPWpGaD
Cefotetan—ALB—Metabolism—BHMT—type 2 diabetes mellitus	5.41e-05	0.00116	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—TGFB1—type 2 diabetes mellitus	5.34e-05	0.00114	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	5.25e-05	0.00112	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—type 2 diabetes mellitus	5.08e-05	0.00109	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	5.03e-05	0.00108	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—ATP2A2—type 2 diabetes mellitus	4.81e-05	0.00103	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—CALM1—type 2 diabetes mellitus	4.79e-05	0.00103	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PTGDS—type 2 diabetes mellitus	4.73e-05	0.00101	CbGpPWpGaD
Cefotetan—ALB—Metabolism—AANAT—type 2 diabetes mellitus	4.73e-05	0.00101	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—APOA1—type 2 diabetes mellitus	4.72e-05	0.00101	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—IL6—type 2 diabetes mellitus	4.69e-05	0.001	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—TRPC6—type 2 diabetes mellitus	4.67e-05	0.000999	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—TNF—type 2 diabetes mellitus	4.62e-05	0.000987	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—F7—type 2 diabetes mellitus	4.59e-05	0.000982	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PRKCB—type 2 diabetes mellitus	4.51e-05	0.000964	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	4.5e-05	0.000962	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GPD2—type 2 diabetes mellitus	4.48e-05	0.000959	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CDO1—type 2 diabetes mellitus	4.48e-05	0.000959	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	4.38e-05	0.000937	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	4.37e-05	0.000934	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	4.36e-05	0.000932	CbGpPWpGaD
Cefotetan—ALB—Metabolism—AK1—type 2 diabetes mellitus	4.28e-05	0.000915	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	4.23e-05	0.000904	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	4.17e-05	0.000891	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	4.17e-05	0.000891	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—ADRA2A—type 2 diabetes mellitus	4.11e-05	0.000879	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PLAT—type 2 diabetes mellitus	4.09e-05	0.000875	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—TIMP1—type 2 diabetes mellitus	4.09e-05	0.000875	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	4.07e-05	0.00087	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	4.04e-05	0.000865	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	4.02e-05	0.00086	CbGpPWpGaD
Cefotetan—ALB—Metabolism—MAT1A—type 2 diabetes mellitus	3.95e-05	0.000844	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SLC5A4—type 2 diabetes mellitus	3.95e-05	0.000844	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—IGF1—type 2 diabetes mellitus	3.95e-05	0.000844	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—AKT2—type 2 diabetes mellitus	3.95e-05	0.000844	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	3.93e-05	0.000841	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	3.86e-05	0.000825	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—NOS1—type 2 diabetes mellitus	3.85e-05	0.000823	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	3.82e-05	0.000818	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PPP1R3C—type 2 diabetes mellitus	3.81e-05	0.000815	CbGpPWpGaD
Cefotetan—ALB—Metabolism—G6PC—type 2 diabetes mellitus	3.81e-05	0.000815	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ND1—type 2 diabetes mellitus	3.81e-05	0.000815	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HBA2—type 2 diabetes mellitus	3.81e-05	0.000815	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ENPP1—type 2 diabetes mellitus	3.81e-05	0.000815	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—SERPINE1—type 2 diabetes mellitus	3.75e-05	0.000802	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PTPN1—type 2 diabetes mellitus	3.74e-05	0.000801	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—IL6—type 2 diabetes mellitus	3.73e-05	0.000797	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GCGR—type 2 diabetes mellitus	3.69e-05	0.00079	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—RASGRP1—type 2 diabetes mellitus	3.68e-05	0.000788	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PIK3R1—type 2 diabetes mellitus	3.58e-05	0.000765	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	3.56e-05	0.00076	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	3.54e-05	0.000758	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CYTB—type 2 diabetes mellitus	3.49e-05	0.000746	CbGpPWpGaD
Cefotetan—ALB—Metabolism—OXCT1—type 2 diabetes mellitus	3.49e-05	0.000746	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SRD5A1—type 2 diabetes mellitus	3.4e-05	0.000727	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	3.38e-05	0.000723	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SOD1—type 2 diabetes mellitus	3.34e-05	0.000714	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ACACA—type 2 diabetes mellitus	3.24e-05	0.000693	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HSD17B3—type 2 diabetes mellitus	3.24e-05	0.000693	CbGpPWpGaD
Cefotetan—ALB—Metabolism—STAR—type 2 diabetes mellitus	3.24e-05	0.000693	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	3.24e-05	0.000693	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—GNB3—type 2 diabetes mellitus	3.23e-05	0.00069	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—IGF2—type 2 diabetes mellitus	3.17e-05	0.000678	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CBS—type 2 diabetes mellitus	3.11e-05	0.000665	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ABCC8—type 2 diabetes mellitus	3.11e-05	0.000665	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—APOB—type 2 diabetes mellitus	3.08e-05	0.000658	CbGpPWpGaD
Cefotetan—ALB—Metabolism—COX2—type 2 diabetes mellitus	2.99e-05	0.00064	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SLC5A2—type 2 diabetes mellitus	2.99e-05	0.00064	CbGpPWpGaD
Cefotetan—ALB—Metabolism—NCOA6—type 2 diabetes mellitus	2.94e-05	0.000629	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	2.94e-05	0.000628	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HSD11B1—type 2 diabetes mellitus	2.89e-05	0.000618	CbGpPWpGaD
Cefotetan—ALB—Metabolism—UCP3—type 2 diabetes mellitus	2.89e-05	0.000618	CbGpPWpGaD
Cefotetan—ALB—Metabolism—UCP2—type 2 diabetes mellitus	2.89e-05	0.000618	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	2.8e-05	0.000599	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.79e-05	0.000597	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—CD36—type 2 diabetes mellitus	2.79e-05	0.000597	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.78e-05	0.000595	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PPP2CA—type 2 diabetes mellitus	2.76e-05	0.00059	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.76e-05	0.000589	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PCK1—type 2 diabetes mellitus	2.72e-05	0.000581	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	2.67e-05	0.000572	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.66e-05	0.00057	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—SRC—type 2 diabetes mellitus	2.65e-05	0.000566	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	2.61e-05	0.000558	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—VEGFA—type 2 diabetes mellitus	2.58e-05	0.000551	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—MMP1—type 2 diabetes mellitus	2.55e-05	0.000544	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HK1—type 2 diabetes mellitus	2.54e-05	0.000544	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2.54e-05	0.000543	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.49e-05	0.000532	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—CALM1—type 2 diabetes mellitus	2.47e-05	0.000529	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GCKR—type 2 diabetes mellitus	2.46e-05	0.000525	CbGpPWpGaD
Cefotetan—ALB—Metabolism—LPA—type 2 diabetes mellitus	2.46e-05	0.000525	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HSD3B2—type 2 diabetes mellitus	2.46e-05	0.000525	CbGpPWpGaD
Cefotetan—ALB—Metabolism—KCNJ11—type 2 diabetes mellitus	2.46e-05	0.000525	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—APOA1—type 2 diabetes mellitus	2.43e-05	0.000521	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	2.37e-05	0.000506	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.36e-05	0.000505	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ALDOB—type 2 diabetes mellitus	2.36e-05	0.000504	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PRKCB—type 2 diabetes mellitus	2.32e-05	0.000497	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—NOS2—type 2 diabetes mellitus	2.29e-05	0.000491	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.29e-05	0.000489	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.25e-05	0.00048	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.24e-05	0.000479	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.22e-05	0.000474	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GLP1R—type 2 diabetes mellitus	2.19e-05	0.000468	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.11e-05	0.000451	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SLC2A2—type 2 diabetes mellitus	2.04e-05	0.000437	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—IGF1—type 2 diabetes mellitus	2.04e-05	0.000435	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—AKT2—type 2 diabetes mellitus	2.03e-05	0.000435	CbGpPWpGaD
Cefotetan—ALB—Metabolism—MTR—type 2 diabetes mellitus	2e-05	0.000428	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CPT1A—type 2 diabetes mellitus	2e-05	0.000428	CbGpPWpGaD
Cefotetan—ALB—Metabolism—NAMPT—type 2 diabetes mellitus	1.96e-05	0.00042	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.95e-05	0.000418	CbGpPWpGaD
Cefotetan—ALB—Metabolism—LIPC—type 2 diabetes mellitus	1.95e-05	0.000417	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HBA1—type 2 diabetes mellitus	1.95e-05	0.000417	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GCK—type 2 diabetes mellitus	1.95e-05	0.000417	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CYP11A1—type 2 diabetes mellitus	1.94e-05	0.000415	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SERPINE1—type 2 diabetes mellitus	1.93e-05	0.000413	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SLC9A1—type 2 diabetes mellitus	1.91e-05	0.000407	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CETP—type 2 diabetes mellitus	1.88e-05	0.000403	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	1.85e-05	0.000395	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	1.85e-05	0.000395	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	1.75e-05	0.000374	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	1.75e-05	0.000374	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	1.75e-05	0.000374	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CTGF—type 2 diabetes mellitus	1.72e-05	0.000368	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	1.7e-05	0.000364	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.68e-05	0.000359	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	1.67e-05	0.000356	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	1.65e-05	0.000352	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	1.6e-05	0.000342	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	1.58e-05	0.000339	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	1.58e-05	0.000339	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	1.54e-05	0.00033	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.54e-05	0.000329	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GCG—type 2 diabetes mellitus	1.52e-05	0.000325	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	1.52e-05	0.000325	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SRC—type 2 diabetes mellitus	1.36e-05	0.000292	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	1.33e-05	0.000284	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GNB3—type 2 diabetes mellitus	1.31e-05	0.00028	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.31e-05	0.00028	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	1.3e-05	0.000279	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CAT—type 2 diabetes mellitus	1.29e-05	0.000275	CbGpPWpGaD
Cefotetan—ALB—Metabolism—APOB—type 2 diabetes mellitus	1.25e-05	0.000267	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	1.22e-05	0.000261	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	1.21e-05	0.00026	CbGpPWpGaD
Cefotetan—ALB—Metabolism—LPL—type 2 diabetes mellitus	1.19e-05	0.000255	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	1.17e-05	0.000249	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GPX1—type 2 diabetes mellitus	1.16e-05	0.000249	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CD36—type 2 diabetes mellitus	1.13e-05	0.000242	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	1.12e-05	0.000239	CbGpPWpGaD
Cefotetan—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	1.07e-05	0.000229	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PPARA—type 2 diabetes mellitus	1.05e-05	0.000225	CbGpPWpGaD
Cefotetan—ALB—Metabolism—AGT—type 2 diabetes mellitus	1.02e-05	0.000218	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CALM1—type 2 diabetes mellitus	1e-05	0.000214	CbGpPWpGaD
Cefotetan—ALB—Metabolism—APOE—type 2 diabetes mellitus	9.99e-06	0.000214	CbGpPWpGaD
Cefotetan—ALB—Metabolism—APOA1—type 2 diabetes mellitus	9.87e-06	0.000211	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PPARG—type 2 diabetes mellitus	8.7e-06	0.000186	CbGpPWpGaD
Cefotetan—ALB—Metabolism—INS—type 2 diabetes mellitus	8.53e-06	0.000182	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	8.48e-06	0.000181	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	7.48e-06	0.00016	CbGpPWpGaD
Cefotetan—ALB—Metabolism—NOS3—type 2 diabetes mellitus	7.48e-06	0.00016	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	6.84e-06	0.000146	CbGpPWpGaD
Cefotetan—ALB—Metabolism—AKT1—type 2 diabetes mellitus	3.44e-06	7.35e-05	CbGpPWpGaD
